Matches in Wikidata for { <http://www.wikidata.org/entity/Q89243431> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q89243431 description "article scientifique publié en 2014" @default.
- Q89243431 description "artículu científicu espublizáu n'ochobre de 2014" @default.
- Q89243431 description "im Oktober 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89243431 description "scientific article published on 26 October 2014" @default.
- Q89243431 description "wetenschappelijk artikel" @default.
- Q89243431 description "наукова стаття, опублікована в жовтні 2014" @default.
- Q89243431 name "Qaly Weightings Based on the Burden of Illness Applied to a Uk Cost-Effectiveness Analysis of Nab-Paclitaxel + Gemcitabine Versus Gemcitabine Alone for the Treatment of Metastatic Pancreatic Cancer" @default.
- Q89243431 name "Qaly Weightings Based on the Burden of Illness Applied to a Uk Cost-Effectiveness Analysis of Nab-Paclitaxel + Gemcitabine Versus Gemcitabine Alone for the Treatment of Metastatic Pancreatic Cancer" @default.
- Q89243431 type Item @default.
- Q89243431 label "Qaly Weightings Based on the Burden of Illness Applied to a Uk Cost-Effectiveness Analysis of Nab-Paclitaxel + Gemcitabine Versus Gemcitabine Alone for the Treatment of Metastatic Pancreatic Cancer" @default.
- Q89243431 label "Qaly Weightings Based on the Burden of Illness Applied to a Uk Cost-Effectiveness Analysis of Nab-Paclitaxel + Gemcitabine Versus Gemcitabine Alone for the Treatment of Metastatic Pancreatic Cancer" @default.
- Q89243431 prefLabel "Qaly Weightings Based on the Burden of Illness Applied to a Uk Cost-Effectiveness Analysis of Nab-Paclitaxel + Gemcitabine Versus Gemcitabine Alone for the Treatment of Metastatic Pancreatic Cancer" @default.
- Q89243431 prefLabel "Qaly Weightings Based on the Burden of Illness Applied to a Uk Cost-Effectiveness Analysis of Nab-Paclitaxel + Gemcitabine Versus Gemcitabine Alone for the Treatment of Metastatic Pancreatic Cancer" @default.
- Q89243431 P1433 Q89243431-14D0D669-B4AD-4AEF-A02E-E2FAA9BF0647 @default.
- Q89243431 P1476 Q89243431-EDAA335A-EF11-479B-A3C6-3D4279396AA3 @default.
- Q89243431 P2093 Q89243431-2B2A845E-166D-4E0A-8A2B-AD93B4FB6739 @default.
- Q89243431 P2093 Q89243431-62D3CDB3-5958-4900-8B7E-A5F38BD89D96 @default.
- Q89243431 P2093 Q89243431-FD3AC672-AB57-4E62-803D-ED3DA17887B4 @default.
- Q89243431 P304 Q89243431-99FF8904-1C1D-4287-86F9-680567D7EDFA @default.
- Q89243431 P31 Q89243431-08246D8A-A627-4124-B419-EECFC2EB11ED @default.
- Q89243431 P356 Q89243431-7553303D-DA36-448A-A462-63D822897612 @default.
- Q89243431 P433 Q89243431-F8B91DEF-5491-41A8-8FE6-109A97BB34DB @default.
- Q89243431 P478 Q89243431-08E12D4D-F91B-4AAA-B9C2-F2D91A265E7B @default.
- Q89243431 P577 Q89243431-15DAB3B7-77D1-453F-B095-9CC0BF221969 @default.
- Q89243431 P698 Q89243431-9EA052C9-BA06-44E2-B058-C22DFC129B15 @default.
- Q89243431 P921 Q89243431-486609F1-FC82-4B4F-9953-1CB4D17D29DD @default.
- Q89243431 P921 Q89243431-5063EF4F-51A1-4276-922D-075951B8CCEB @default.
- Q89243431 P356 J.JVAL.2014.08.2317 @default.
- Q89243431 P698 27202304 @default.
- Q89243431 P1433 Q15766908 @default.
- Q89243431 P1476 "Qaly Weightings Based on the Burden of Illness Applied to a Uk Cost-Effectiveness Analysis of Nab-Paclitaxel + Gemcitabine Versus Gemcitabine Alone for the Treatment of Metastatic Pancreatic Cancer" @default.
- Q89243431 P2093 "A Parnaby" @default.
- Q89243431 P2093 "D Gladwell" @default.
- Q89243431 P2093 "W Cowell" @default.
- Q89243431 P304 "A642" @default.
- Q89243431 P31 Q13442814 @default.
- Q89243431 P356 "10.1016/J.JVAL.2014.08.2317" @default.
- Q89243431 P433 "7" @default.
- Q89243431 P478 "17" @default.
- Q89243431 P577 "2014-10-26T00:00:00Z" @default.
- Q89243431 P698 "27202304" @default.
- Q89243431 P921 Q212961 @default.
- Q89243431 P921 Q614165 @default.